Interestingly, MMP7 expression was observed to be the highest in the co-existent adenomyosis–endometriosis group, suggesting a synergistic effect on ECM degradation in the presence of dual pathology, potentially driving more aggressive tissue remodeling. Here, MMP7 is linked to adenomyosis.